The biopharmaceutical industry faces increasing pressure to more rapidly develop innovative products. A potential therapeutic must face many hurdles: preclinical, manufacturing, and clinical efficacy to name a few. Method of all, therapeutic sample supply is one of initial hurdles for early phase product development. Break through challenge is to pass over the hurdles in an efficient and collaborative manner during out the beginning of development.At KITECH, we established strategy of cell culture process development in the early stage of development. Overall our goal is supporting service to medium or small firms which develop biopharmaceutical product using delivery of their precious product of sample for proof of concept study. We present structural and strategic approach for early phase process development, without large resources using 6 sigma.
키워드
cell culturefed-batch cultureadditive supplement
저자
Sam-Sook Sul [ Department of Biologics Manufacturing, Korea Biotechnology Commercialization Center ]
Yong-Hoon Chung [ # 2-3 Special Research Center, 198-59 Hoopyung-dong, Chuncheon City, Kangwon-do, Korea ]
Joon-Chul Lee [ Department of Biologics Manufacturing, Korea Biotechnology Commercialization Center ]
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동